U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710781) titled 'A Multicenter, Open Label Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies' on July 13.
Brief Summary: Prospective, multi-center open label study of HLA-partially to fully matched allogeneic cryopreserved deceased donor bone marrow transplantation and living donor transplantation for patients with hematologic malignancies.
Study Start Date: Dec. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Hematologic Malignancy
Acute Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Biphenotypic Leukemia
Acute Undifferentiated L...